LCD ID Number: L39007 Status: A-Approved
LCD Title: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
Geographic Jurisdiction: Arizona Other Jurisdictions
Original Determination Effective Date:
08/08/2022
Original Determination Ending Date:
Revision Effective Date:
07/27/2023
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary.
42 CFR 410.32(a) Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions.
CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests §80.1.1 Certification Changes
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|